Stifel Financial’s Regenxbio RGNX Stock Holding History

Stifel Financial’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.72M	Buy	560,727 +167,958	+43%	+$1.39M	0.01%	1244
2026 Q1	$3.29M	Buy	392,769 +57,723	+17%	+$606K	﹤0.01%	1612
2025 Q4	$4.82M	Buy	335,046 +14,636	+5%	+$182K	﹤0.01%	1353
2025 Q3	$3.09M	Buy	320,410 +9,303	+3%	+$82.3K	﹤0.01%	1587
2025 Q2	$2.55M	Sell	311,107 -17,859	-5%	-$149K	﹤0.01%	1666
2025 Q1	$2.35M	Buy	328,966 +140,122	+74%	+$1.04M	﹤0.01%	1647
2024 Q4	$1.46M	Buy	188,844 +39,564	+27%	+$371K	﹤0.01%	2001
2024 Q3	$1.57M	Buy	149,280 +17,563	+13%	+$214K	﹤0.01%	1934
2024 Q2	$1.54M	Buy	131,717 +41,122	+45%	+$640K	﹤0.01%	1903
2024 Q1	$1.91M	Buy	90,595 +22,646	+33%	+$403K	﹤0.01%	1754
2023 Q4	$1.22M	Buy	67,949 +2,148	+3%	+$37.8K	﹤0.01%	2009
2023 Q3	$1.08M	Buy	65,801 +5,824	+10%	+$106K	﹤0.01%	2000
2023 Q2	$1.2M	Buy	59,977 +13,678	+30%	+$264K	﹤0.01%	1963
2023 Q1	$876K	Buy	46,299 +12,004	+35%	+$266K	﹤0.01%	2145
2022 Q4	$778K	Buy	34,295 +6,497	+23%	+$147K	﹤0.01%	2182
2022 Q3	$735K	Buy	27,798 +2,538	+10%	+$75.3K	﹤0.01%	2177
2022 Q2	$624K	Buy	25,260 +4,751	+23%	+$119K	﹤0.01%	2336
2022 Q1	$681K	Buy	20,509 +5,626	+38%	+$156K	﹤0.01%	2388
2021 Q4	$487K	Buy	14,883 +3,975	+36%	+$135K	﹤0.01%	2602
2021 Q3	$457K	Buy	10,908 +4,669	+75%	+$168K	﹤0.01%	2624
2021 Q2	$242K	Buy	+6,239	New	+$223K	﹤0.01%	3037

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Stifel Financial's RGNX Position: Q2 2026 in Review

Stifel Financial increased its Regenxbio (RGNX) stake by 43% in Q2 2026, buying an estimated $1.39M and bringing the position to 560,727 shares worth $6.72M. The position accounts for 0.01% of the portfolio, ranked #1244.

Stifel Financial first reported a position in RGNX in Q2 2021 and has held it in 21 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

Stifel Financial held 560,727 shares of Regenxbio worth $6.72M as of Q2 2026.
Stifel Financial bought 167,958 Regenxbio shares in Q2 2026, an estimated $1.39M.
Regenxbio made up 0.01% of Stifel Financial's portfolio in Q2 2026, its #1244 holding.
Stifel Financial first reported a position in Regenxbio in Q2 2021 and has held it in 21 quarters since.
165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.